Kiniksa Pharmaceuticals International, plc (KNSA) Operating income 2017–2025
Kiniksa Pharmaceuticals International, plc (KNSA) annual operating income history from SEC filings — each fiscal year as reported.
$77.2MFY2025 · since FY2017: -$65.4M → $77.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $77.2M | +269.3% |
| FY2024 | -$45.6M | -81.0% |
| FY2023 | -$25.2M | -357.8% |
| FY2022 | $9.8M | +106.2% |
| FY2021 | -$156.6M | +0.5% |
| FY2020 | -$157.4M | +7.4% |
| FY2019 | -$170.0M | -57.1% |
| FY2018 | -$108.2M | -65.4% |
| FY2017 | -$65.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice